Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Genetics
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Genetics. 2009;2:26-33
Published online before print January 23, 2009, doi: 10.1161/CIRCGENETICS.108.817304
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/1/26    most recent
CIRCGENETICS.108.817304v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ridker, P. M.
Right arrow Articles by Chasman, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ridker, P. M.
Right arrow Articles by Chasman, D. I.
Related Collections
Right arrow Genomics
Right arrow Ischemic biology - basic studies
Right arrow Epidemiology
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

Original Articles

Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction

Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study

Paul M. Ridker, MD, MPH; Guillaume Paré, MD, MSc; Alex N. Parker, PhD; Robert Y.L. Zee, PhD, MPH; Joseph P. Miletich, MD and Daniel I. Chasman, PhD

From the Center for Cardiovascular Disease Prevention (P.M.R., G.P., R.Y.L.Z., D.I.C.) and The Donald W Reynolds Center for Cardiovascular Research (P.M.R., R.Y.L.Z., D.I.C.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; and Amgen, Inc (A.N.P., J.P.M.), Cambridge Mass.

Correspondence to Daniel I. Chasman, PhD or Paul M Ridker, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Ave E, Boston, MA 02215. E-mail dchasman{at}rics.bwh.harvard.edu

Received August 25, 2008; accepted December 3, 2008.

Background— Recent trial data have challenged the hypothesis that cholesteryl ester transfer protein (CETP) and high-density lipoprotein cholesterol (HDL-C) have causal roles in atherothrombosis. One method to evaluate this issue is to examine whether polymorphisms in the CETP gene that impact on HDL-C levels also impact on the future development of myocardial infarction.

Methods and Results— In a prospective cohort of 18 245 initially healthy American women, we examined over 350 000 singe-nucleotide polymorphisms (SNPs) first to identify loci associated with HDL-C and then to evaluate whether significant SNPs within these loci also impact on rates of incident myocardial infarction during an average 10-year follow-up period. Nine loci on 9 chromosomes had 1 or more SNPs associated with HDL-C at genome-wide statistical significance (P<5x10–8). However, only SNPs near or in the CETP gene at 16q13 were associated with both HDL-C and risk of incident myocardial infarction (198 events). For example, SNP rs708272 in the CETP gene was associated with a per-allele increase in HDL-C levels of 3.1 mg/dL and a concordant 24% lower risk of future myocardial infarction (age-adjusted hazard ratio, 0.76; 95% CI, 0.62 to 0.94), consistent with recent meta-analysis. Independent and again concordant effects on HDL-C and incident myocardial infarction were also observed at the CETP locus for rs4329913 and rs7202364. Adjustment for HDL-C attenuated but did not eliminate these effects.

Conclusion— In this prospective cohort of initially healthy women, SNPs at the CETP locus impact on future risk of myocardial infarction, supporting a causal role for CETP in atherothrombosis, possibly through an HDL-C mediated pathway.

Key Words: HDL-cholesterol • myocardial infarction • atherosclerosis • genetic association


 

CLINICAL PERSPECTIVE

Guest Editor for this article was Donna K. Arnett, PhD.


Related Article

Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study
Paul M. Ridker, Guillaume Paré, Alex N. Parker, Robert Y.L. Zee, Joseph P. Miletich, and Daniel I. Chasman
Circ Cardiovasc Genet 2009 2: 26-33. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
CirculationHome page
R. Sofat, A. D. Hingorani, L. Smeeth, S. E. Humphries, P. J. Talmud, J. Cooper, T. Shah, M. S. Sandhu, S. L. Ricketts, S. M. Boekholdt, et al.
Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms
Circulation, January 5, 2010; 121(1): 52 - 62.
[Abstract] [Full Text] [PDF]